Anti-HIV agents: design and discovery of new potent RT inhibitors
- 5 February 2003
- journal article
- review article
- Published by Elsevier in Il Farmaco
- Vol. 58 (3), 259-263
- https://doi.org/10.1016/s0014-827x(03)00024-7
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Synthesis and anti-HIV activity of 1-(2,6-difluorophenyl)-1H,3H-thiazolo[3,4-a]benzimidazole structurally-related 1,2-substituted benzimidazolesIl Farmaco, 2002
- Synthesis, biological activity, pharmacokinetic properties and molecular modelling studies of novel 1H,3H-oxazolo[3,4-a]benzimidazoles: non-nucleoside HIV-1 reverse transcriptase inhibitors.Antiviral Chemistry and Chemotherapy, 2001
- Discovery of 2,3-diaryl-1,3-thiazolidin-4-ones as potent anti-HIV-1 agentsBioorganic & Medicinal Chemistry Letters, 2001
- Structural Basis for the Resilience of Efavirenz (DMP-266) to Drug Resistance Mutations in HIV-1 Reverse TranscriptaseStructure, 2000
- Novel compounds in preclinical/early clinical development for the treatment of HIV infectionsReviews in Medical Virology, 2000
- Nonnucleoside reverse transcriptase inhibitorsDrugs of the Future, 2000
- Comparative molecular field analysis (CoMFA) and docking studies of non-nucleoside HIV-1 RT inhibitors (NNIs)Bioorganic & Medicinal Chemistry, 1999
- Synthesis and Biological Activity of Novel Nonnucleoside Inhibitors of HIV-1 Reverse Transcriptase. 2-Aryl-Substituted BenzimidazolesJournal of Medicinal Chemistry, 1997
- Structural Features and Anti-Human Immunodeficiency Virus (HIV) Activity of the Isomers of 1-(2′,6′-Difluorophenyl)-1H,3H-Thiazolo[3,4-a]Benzimidazole, a Potent Non-Nucleoside HIV-1 Reverse Transcriptase InhibitorAntiviral Chemistry and Chemotherapy, 1997
- A computational procedure for determining energetically favorable binding sites on biologically important macromoleculesJournal of Medicinal Chemistry, 1985